Quantity increase and functional affinity/avidity decrease of anti-FcεRI and anti-IgE autoantibodies in chronic spontaneous urticaria.

Autor: Joerg L; Division of Allergologie and Clinical Immunology, Department of Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Mueller-Wirth N; ADR-AC GmbH, Adverse Drug Reactions, Analysis and Consulting, Bern, Switzerland., Kammermann K; ADR-AC GmbH, Adverse Drug Reactions, Analysis and Consulting, Bern, Switzerland., Stalder O; CTU Bern, University of Bern, Switzerland., Pichler W; ADR-AC GmbH, Adverse Drug Reactions, Analysis and Consulting, Bern, Switzerland., Hausmann O; ADR-AC GmbH, Adverse Drug Reactions, Analysis and Consulting, Bern, Switzerland.; Löwenpraxis Luzern, Lucerne, Switzerland.
Jazyk: angličtina
Zdroj: European annals of allergy and clinical immunology [Eur Ann Allergy Clin Immunol] 2024 Nov; Vol. 56 (6), pp. 271-280. Date of Electronic Publication: 2023 Dec 13.
DOI: 10.23822/EurAnnACI.1764-1489.320
Abstrakt: Summary: Background. Patients with autoimmune forms of chronic spontaneous ur-ticaria (aiCSU) exhibit autoantibodies against the high-affinity IgE recep-tor (FcεRI) and IgE. As the presence of these autoantibodies does not cor-relate with disease activity, the functional affinity/avidity may be relevant in aiCSU. This exploratory study aimed to characterize the quantity and avidity of autoantibodies against IgE and FcεRI over 6 months. Methods. The serum of 49 patients with CSU and 30 healthy control subjects was obtained at baseline and 6 months. Serum was analyzed by ELISA, to determine the quantity and avidity of anti-IgE and anti-FcεRI autoan-tibodies, and by basophil activation test (CU-BAT). Results. An increase in the quantity of anti-FcεRI and anti-IgE antibodies and a simultaneous decrease in avidity was found in all patients with CSU after 6 months: median anti-IgE increased from 6.7 ng/mL (IQR 5.1-12.5) to 23.8 ng/mL (IQR 12.3-121.5), p < 0.001, median anti-FcεRI from 52.4 ng/mL (IQR 26.3-111.4) to 129.5 ng/mL (IQR 73.7-253.7), p < 0.001. Me-dian anti-IgE avidity decreased from 75.8% (IQR 55.3-90.8) to 56.4% (IQR 30.6-76.2), p = 0.019 and median anti-FcεRI avidity from 75.1% (IQR 49.8-90.0) to 52.2 (IQR 38.2-60.1), p < 0.001. In contrast, the frequency of activated basophils did not change significantly over time. Surprisingly, autoantibody avidity did not correlate with basophil acti-vation. Conclusions. Both the quantity and avidity of anti-FcεRI and anti-IgE antibodies change over time, demonstrating that the CU-BAT is more suitable to diagnose aiCSU. In addition, the avidity of anti-FcεRI and anti-IgE antibodies do not correlate with CU-BAT and disease activ-ity, suggesting that further factors independent of anti-FcεRI and anti-IgE autoantibodies contribute to aiCSU.
Databáze: MEDLINE